Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVISO: Flecainide vs Bisoprolol for Premature Ventricular Contractions
2025-524584-20-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Premature ventricular complexes (PVC) comparing Flecainide with Bisoprolol (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Aug 2026; status: authorised.
02
Drugs
flecainidebisoprolol
03
Conditions
Premature ventricular complexes (PVC)
Beyond the preview
Go deeper on 2025-524584-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524584-20-00.